论文信息 - Chemotherapy for Adult Acute Myeloid Leukemia: Study Results from the Acute Myeloid Leukemia Cooperative Group and Overview - 字舞流文

Chemotherapy for Adult Acute Myeloid Leukemia: Study Results from the Acute Myeloid Leukemia Cooperative Group and Overview

K. Straif | W. Siegert | E. Thiel | W. Hiddemann | K. Mainzer | A. Ho | R. Mertelsmann | W. Ludwig | D. Hossfeld | B. Emmerich | M. Sauerland | A. Heinecke | T. Büchner | E. Lengfelder | C. Aul | H. Eimermacher | G. Maschmeyer | P. Koch | H. König | H. Löffler | W. Gassmann | M. Nowrousian | K. Hellriegel | H. Fülle | D. Urbanitz | R. Kuse | H. Köppler | M. Planker | J. Karow | F. Overkamp | H. Bartels | F. Wendt | A. Mohr | K. Zurborn | G. Middelhoff | L. Nowicki | H. Fuhr | W. Augener | M. Schroeder | C. Anders | H. Seibt | K. Vaupel | A. V. Paleske | J. Schwammborn | R. Bonhuijsen-Ant

[1] W. Hiddemann,et al. Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemias in aplasia and at high risk of early death. , 1988, Behring Institute Mitteilungen.

[2] M. Oken,et al. Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3] H. Preisler,et al. Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study. , 1987, Blood.

[4] R. Gray,et al. PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIAL , 1986, The Lancet.

[5] R. Willemze,et al. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia: A leukemia‐lymphoma group trial of the EORTC , 1986, Cancer.

[6] W. Hiddemann,et al. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7] T. Büchner,et al. ROLE OF CHEMOTHERAPY FOR AML IN REMISSION , 1985, The Lancet.

[8] D. S. Gordon,et al. A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial. , 1984, Blood.

[9] C. Begg,et al. A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia. , 1984, Blood.

[10] F. Cavalli,et al. ACUTE MYELOGENOUS LEUKAEMIA: MAINTENANCE CHEMOTHERAPY AFTER EARLY CONSOLIDATION TREATMENT DOES NOT PROLONG SURVIVAL , 1984, The Lancet.

[11] N. Nissen,et al. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. , 1982, Blood.

[12] C. Bloomfield,et al. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. , 1981, Blood.

[13] E. Schultheisz. [CARL GUSTAV CARUS]. , 1964, Orvosi hetilap.